Free Trial
→ Stunning Trump Manhattan Project Now Underway (From Banyan Hill Publishing) (Ad)

10 Best Penny Stocks to Buy Now - 8 of 10

Slide 8
Back to 7
Continue to 9
 
Back to 7
Continue to 9
 

Immunic (NASDAQ:IMUX)

Number of Upgrades from Top-Ranked Analysts
4 (in the last 90 days)
Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$12.67 (1,187.8% Upside)

About Immunic

Immunic logoImmunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/7/2025D. Boral CapitalReiterated RatingBuy ➝ Buy$17.00 ➝ $17.00
11/25/2024HC WainwrightInitiated CoverageBuy$10.00
9/16/2024EF Hutton Acquisition Co. IUpgradeStrong-Buy
9/9/2024Leerink PartnrsUpgradeStrong-Buy
9/9/2024Leerink PartnersReiterated RatingOutperform$5.00
8/27/2024B. RileyInitiated CoverageBuy$6.00
7/16/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$28.00 ➝ $28.00
4/5/2024Brookline Capital ManagementReiterated RatingBuy$10.00
11/14/2023WedbushReiterated RatingOutperform$7.00
10/10/2023WedbushBoost Price TargetOutperform ➝ Outperform$5.00 ➝ $7.00
Slide 8
Back to 7
Continue to 9
 

More From MarketBeat
Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
7 Undervalued Growth Stocks Ready for Reversal
Traders and investors are digesting what a 50-basis point (0.50%) cut in interest rates means for stocks. If y...
MarketBeat
Did You See Trump’s Manhattan Project Bombshell?
This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...
Banyan Hill Publishing | Sponsored
7 Stocks to Buy if Inflation Remains Higher for Longer
Every month, investors get several key economic indicators that report the trajectory of inflation. The Cons...
MarketBeat
Kamala’s final humiliation
Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...
Porter & Company | Sponsored
7 Low Beta Stocks for the Risk-Averse Investor
Investing is about balancing risk and reward. That's why regardless of market conditions, many investors with ...
MarketBeat